2015
DOI: 10.1016/j.jinorgbio.2015.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Structure, physicochemical and biological properties of new complex salt of aqua-(nitrilotriacetato-N,O,O′,O″)-oxidovanadium(IV) anion with 1,10-phenanthrolinium cation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
15
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 22 publications
(20 citation statements)
references
References 46 publications
5
15
0
Order By: Relevance
“…The C–O bond lengths of nta (Table 2) confirm a one-and-a-half character of the bonds, caused by the delocalization of the π electrons of the carboxylate groups involved in the coordination of V(IV). The other vanadium–oxygen bond distances in the investigated compound are comparable with those found for its phenanthroline analogue, [phenH][VO(nta)(H 2 O)](H 2 O) 0.5 (Tesmar et al 2015).
Fig.
…”
Section: Resultssupporting
confidence: 76%
See 3 more Smart Citations
“…The C–O bond lengths of nta (Table 2) confirm a one-and-a-half character of the bonds, caused by the delocalization of the π electrons of the carboxylate groups involved in the coordination of V(IV). The other vanadium–oxygen bond distances in the investigated compound are comparable with those found for its phenanthroline analogue, [phenH][VO(nta)(H 2 O)](H 2 O) 0.5 (Tesmar et al 2015).
Fig.
…”
Section: Resultssupporting
confidence: 76%
“…Recently, it has been proven in one specific case that the cation formed by a protonation of N-heterocyclic compound (i.e. phenH) is able to stabilize mononuclear [VO(nta)(H 2 O)] − species (Tesmar et al 2015). In this paper this finding is also confirmed for other protonated N-heterocyclic compound, i.e.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Oxidovanadium(IV) complexes are the subject of interest to many research groups since it has been found that they reveal an interesting biological activity. Much attention has been focused on studies of their insulin‐mimetic (‐enhancing) properties, the anticancer properties as well as the cytoprotective activity against an oxidative damage . However, the main challenge in designing new oxidovanadium(IV) complexes for the future use in medicine is the selection of the appropriate type of ligands in order to overcome the balance existing between the therapeutic action and adverse effects exerted by vanadium compounds by shifting this balance toward the beneficial side.…”
Section: Introductionmentioning
confidence: 99%